|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 7 |
| 1.1 List of Tables | 6 | 2 |
| 1.2 List of Figures | 8 | 1 |
| 2 Introduction | 9 | 1 |
| 2.1 What Is This Report About? | 9 | 1 |
| 3 Definitions of the Markets Covered in the Report | 10 | 1 |
| 3.1 Drug Delivery Devices | 10 | 1 |
| 3.2 Inhalation Systems | 10 | 1 |
| 3.3 Infusion Systems | 10 | 1 |
| 4 Drug Delivery Devices in South and Central America | 11 | 8 |
| 4.1 Drug Delivery Devices, South and Central America, Overall Revenue ($ mn), 2000-2015 | 11 | 4 |
| 4.2 Drug Delivery Devices, South and Central America, Category Volume (Units), 2000-2015 | 15 | 3 |
| 4.3 Drug Delivery Devices, South and Central America, Company share (2007-2008) | 18 | 1 |
| 5 Drug Delivery Devices In Argentina | 19 | 10 |
| 5.1 Drug Delivery Devices, Argentina, Overall Revenue ($ mn), 2000-2015 | 19 | 3 |
| 5.2 Drug Delivery Devices, Argentina, Category Volume (Units), 2000-2015 | 22 | 3 |
| 5.3 Drug Delivery Devices, Argentina, Distribution Share (2007-2008) | 25 | 1 |
| 5.3.1 Infusion Systems Distribution Share (2007-2008) | 25 | 1 |
| 5.3.2 Inhalation Systems Distribution Share (2007-2008) | 25 | 1 |
| 5.4 Drug Delivery Devices, Argentina, Company Share (2007-2008) | 26 | 1 |
| 5.4.1 Drug Delivery Devices, Argentina, Company Share (2007-2008) | 26 | 1 |
| 5.4.2 Infusion Systems, Argentina, Company Share (2007-2008) | 27 | 1 |
| 5.4.3 Inhalation Systems, Argentina, Company Share (2007-2008) | 28 | 1 |
| 6 Drug Delivery Devices In Brazil | 29 | 10 |
| 6.1 Drug Delivery Devices, Brazil, Overall Revenue ($ mn), 2000-2015 | 29 | 3 |
| 6.2 Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2015 | 32 | 3 |
| 6.3 Drug Delivery Devices, Brazil, Distribution Share (2007-2008) | 35 | 1 |
| 6.3.1 Infusion Systems Distribution Share (2007-2008) | 35 | 1 |
| 6.3.2 Inhalation Systems Distribution Share (2007-2008) | 35 | 1 |
| 6.4 Drug Delivery Devices, Brazil, Company Share (2007-2008) | 36 | 1 |
| 6.4.1 Drug Delivery Devices, Brazil, Company Share (2007-2008) | 36 | 1 |
| 6.4.2 Infusion Systems, Brazil, Company Share (2007-2008) | 37 | 1 |
| 6.4.3 Inhalation Systems, Brazil, Company Share (2007-2008) | 38 | 1 |
| 7 Drug Delivery Devices In Mexico | 39 | 10 |
| 7.1 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), 2000-2015 | 39 | 3 |
| 7.2 Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2015 | 42 | 3 |
| 7.3 Drug Delivery Devices, Mexico, Distribution Share (2007-2008) | 45 | 1 |
| 7.3.1 Infusion Systems Distribution Share (2007-2008) | 45 | 1 |
| 7.3.2 Inhalation Systems Distribution Share (2007-2008) | 45 | 1 |
| 7.4 Drug Delivery Devices, Mexico, Company Share (2007-2008) | 46 | 1 |
| 7.4.1 Drug Delivery Devices, Mexico, Company Share (2007-2008) | 46 | 1 |
| 7.4.2 Infusion Systems, Mexico, Company Share (2007-2008) | 47 | 1 |
| 7.4.3 Inhalation Systems, Mexico, Company Share (2007-2008) | 48 | 1 |
| 8 Overview of Key Companies in South and Central America Drug Delivery Devices Market | 49 | 11 |
| 8.1 Terumo Corporation | 49 | 1 |
| 8.1.1 Company Overview | 49 | 1 |
| 8.2 Smiths Medical | 49 | 1 |
| 8.2.1 Company Overview | 49 | 1 |
| 8.3.1 Company Overview | 50 | 1 |
| 8.4 NIPRO CORPORATION | 51 | 1 |
| 8.4.1 Company Overview | 51 | 1 |
| 8.4.2 NIPRO CORPORATION Pipeline Products | 51 | 1 |
| 8.4.2.1 NIPRO CORPORATION Pipeline Products By Equipment Type | 51 | 1 |
| 8.4.2.2 NIPRO CORPORATION Pipeline Products By Development Stage | 52 | 1 |
| 8.4.2.3 NIPRO CORPORATION Pipeline Products By Therapy Area | 52 | 1 |
| 8.5 GlaxoSmithKline plc | 53 | 1 |
| 8.5.1 Company Overview | 53 | 1 |
| 8.6 Boehringer Ingelheim GmbH | 54 | 1 |
| 8.6.1 Company Overview | 54 | 1 |
| 8.7 Consort Medical plc | 55 | 1 |
| 8.7.1 Company Overview | 55 | 1 |
| 8.7.2 Bespak plc Pipeline Products | 55 | 1 |
| 8.7.2.1 Bespak plc Pipeline Products By Equipment Type | 55 | 1 |
| 8.7.2.2 Bespak plc Pipeline Products By Development Stage | 55 | 1 |
| 8.7.2.3 Bespak plc Pipeline Products By Therapy Area | 55 | 1 |
| 8.8 Baxter International Inc. | 56 | 1 |
| 8.8.1 Company Overview | 56 | 1 |
| 8.9 AstraZeneca PLC | 56 | 1 |
| 8.9.1 Company Overview | 56 | 1 |
| 8.10 Cardinal Health, Inc. | 57 | 1 |
| 8.10.1 Company Overview | 57 | 1 |
| 8.11 B. Braun Melsungen AG | 57 | 1 |
| 8.11.1 Company Overview | 57 | 1 |
| 8.12 Hospira, Inc. | 58 | 1 |
| 8.13 Fresenius Kabi AG | 59 | 1 |
| 8.13.1 Company Overview | 59 | 1 |
| 9 Appendix | 60 | 5 |
| 9.1 Global Markets Direct Research Methodology | 60 | 1 |
| 9.2 Secondary Research | 61 | 1 |
| 9.3 Primary Research | 61 | 1 |
| 9.4 Models | 62 | 1 |
| 9.5 Forecasts | 62 | 1 |
| 9.6 Expert Panel Validation | 62 | 1 |
| 9.7 Currency Conversion | 63 | 1 |
| 9.8 Contact Us | 64 | 1 |
| 9.9 Disclaimer | 64 | 1 |
